Xilio Therapeutics, Inc. (XLO) Social Stream
Xilio Therapeutics Inc (XLO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering XLO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
XLO reports an average of 179.02% for its upside potential over the past 125 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
XLO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Xilio Therapeutics Inc's number of analysts covering the stock is higher than 58.14% of all US stocks.
- In the context of all US stocks, Xilio Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 189.6% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Xilio Therapeutics Inc's variance in analysts' estimates is lower than 57.97% of them.
- In the context of stocks in the small market cap category, Xilio Therapeutics Inc's average analyst price target is higher than 150.05% of them.
In the Pharmaceutical Products industry, XERS, XENE, and XBIT are the three stocks most similar to Xilio Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding XLO using the data that counts. Try POWR Ratings for free.